Excellagen Case Study – Dr. Howard Kimmel, Cleveland, OH, Case Study Two | New Treatment for Diabetic Foot Ulcers | Diabetes and Foot Care

NEWS | CONTACT US

Diabetic Foot Ulcer Case Study. Arthur Tallis, DPM, FACFAS, Phoenix, AZ

Day of 1st Application

Week 2 Prior to 2nd
Application. 60% Reduction

Week 4. 80% Reduction

Patient Data
Age	55
Sex	Female
General Health Status	Charcot, Insulin Dependent Diabetes Mellitus
Wound	Diabetic Foot Ulcer present for 40 Weeks
Prior Treatments	Surgical Debridement/Partial Calcanectomy, Non-Weightbearing, Dermagraft
Excellagen Treatment	Bi-weekly for 4 weeks

Excellagen is indicated for the management of wounds. Although many patients benefit from the use of the product, results may vary. Please see full prescribing information.

Download
Case Study

Excellagen is indicated for the management of wounds including partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/ undermined wounds, surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, and skin tears) and draining wounds. Excellagen is contraindicated for individuals with a known sensitivity to products of bovine origin.

Excellagen is for use by healthcare professionals in the United States. All information, including the prescribing information for Excellagen, follows laws, regulatory requirements, and medical practices for the United States only and may not be appropriate for use outside of the United States. Detailed information about Excellagen can be found in the Package Insert and the Directions for Use.